Stock listing
NASDAQ:SGEN Seagen Inc Stock
Follow Seagen Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SGEN
$228.74 USD
Close on Dec 13, 2023 · No longer trades
- Lowest – highest close
- $2.25 – $228.90 USDSince Mar 7, 2001 · lowest Apr 11, 2003 · highest Dec 12, 2023
Delisted NASDAQ:SGEN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SGEN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Seagen Inc on 6ix
- Calls
- 9 calls with a replay · 9 with a transcript · latest Feb 15, 2023
- Decks
- 1 deck · latest Mar 13, 2023
Events
| Call | When | Status |
|---|---|---|
| Seagen (SGEN) Q4 2022 Earnings Call | Wed, Feb 15, 2023 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q3 2022 Earnings Call | Thu, Oct 27, 2022 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q2 2022 Earnings Call | Thu, Jul 28, 2022 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q1 2022 Earnings Call | Thu, Apr 28, 2022 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q4 2021 Earnings Call | Wed, Feb 09, 2022 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q3 2021 Earnings Call | Thu, Oct 28, 2021 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q2 2021 Earnings Call | Thu, Jul 29, 2021 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q1 2021 Earnings Call | Thu, Apr 29, 2021 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q4 2020 Earnings Call | Thu, Feb 11, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (March 2023) | Merger or acquisition | 20 slides | Mar 13, 2023 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Felix Baker Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Feb 8, 2010 – Jun 19, 2012 · Past); Synageva BioPharma Corp (Director · Aug 14, 2007 – Jun 22, 2015 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past) | Director · May 25, 2007 – Dec 14, 2023 · Past |
| Julian Baker Other companies: Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Director · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Managing Partner, Baker Brothers Investments | Chairman, Incyte · Since at least Apr 25, 2006); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Apr 6, 2010 – Jun 19, 2012 · Past); Innoviva, Inc. (Director · Apr 26, 2006 – Apr 26, 2006 · Past); Genomic Health Inc (Director · Apr 25, 2006 – Oct 1, 2019 · Past); Synageva BioPharma Corp (Director · Apr 25, 2006 – Jun 22, 2015 · Past); Neurogen Corp (Director · Mar 15, 2006 – Dec 15, 2009 · Past) | Director · Jun 9, 2006 – Dec 14, 2023 · Past |
| Ted W Love Other companies: Lisata Therapeutics, Inc. (Director · Since at least Sep 17, 2026); Jazz Pharmaceuticals plc (Director · Since at least Dec 1, 2025); Gilead Sciences, Inc. (Director · Since at least Feb 1, 2024); Structure Therapeutics, Inc. (Director · Since at least Aug 3, 2023); Royalty Pharma plc (Director · Since at least Jul 30, 2020); Portola Pharmaceuticals Inc (Director · Sep 18, 2019 – Jul 2, 2020 · Past); Global Blood Therapeutics Inc (President and CEO, Director · Aug 11, 2015 – Oct 5, 2022 · Past); Cascadian Therapeutics Inc (Director · Sep 5, 2013 – Mar 9, 2018 · Past); Savara, Inc. (Director · Sep 5, 2012 – Jun 19, 2013 · Past); Humanigen Inc (Director · Aug 10, 2012 – Jul 10, 2015 · Past); Amicus Therapeutics Inc (Director · Jun 13, 2012 – Jun 4, 2020 · Past); Bio-Rad Laboratories, Inc. (Director · Mar 24, 2010 – Mar 24, 2010 · Past); Onyx Pharmaceuticals Inc (EVP, R&D and Tech. Operations · Feb 1, 2010 – Jul 25, 2012 · Past); Affymax Inc (Director · Dec 14, 2006 – Jun 13, 2012 · Past); Santarus Inc (Director · Jun 7, 2006 – Jan 2, 2014 · Past); Oruka Therapeutics, Inc. (Director · Mar 7, 2006 – Feb 5, 2010 · Past) | Director · Aug 16, 2020 – Dec 14, 2023 · Past |
| David W. Gryska Other companies: Celcuity Inc. (Director · Since at least Oct 1, 2026); Definium Therapeutics, Inc. (Audit · Since at least Jun 21, 2023); Forte Biosciences, Inc. (Director · Since at least Jan 10, 2023); GW Pharmaceuticals plc (Director · Sep 9, 2020 – May 5, 2021 · Past); Incyte Corporation (Executive Vice President, CFO · Oct 31, 2014 – Jul 16, 2018 · Past); PDL BioPharma Inc (Director · Mar 6, 2014 – Dec 30, 2020 · Past); Argos Therapeutics Inc (Director · Feb 6, 2014 – Feb 6, 2014 · Past); Aerie Pharmaceuticals Inc. (Director · Oct 25, 2013 – Nov 21, 2022 · Past); Hyperion Therapeutics Inc (Director · Jul 25, 2012 – Apr 15, 2013 · Past); Myrexis Inc (Chief Operating Officer, Director · May 11, 2012 – May 11, 2012 · Past); Celgene Corporation (Chief Financial Officer · Dec 6, 2006 – Jul 13, 2010 · Past) | Director · Feb 14, 2006 – Dec 14, 2023 · Past |
| Daniel G. Welch Other companies: Prothena Corporation plc (Chair of the Board · Since at least Feb 21, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Ultragenyx Pharmaceutical Inc. (Director · Since at least Apr 8, 2015); Nuvation Bio Inc. (Director · Feb 10, 2021 – May 24, 2024 · Past); AveXis Inc (Director · Feb 10, 2016 – May 15, 2018 · Past); Intercept Pharmaceuticals Inc (Director · Nov 24, 2015 – May 28, 2020 · Past); Corium International Inc (Director · Apr 2, 2014 – Apr 2, 2014 · Past); Hyperion Therapeutics Inc (Director · Aug 23, 2012 – May 7, 2015 · Past); InterMune Inc (Chairman, CEO and President, Director · Mar 15, 2006 – Sep 29, 2014 · Past) | Director · Jun 13, 2007 – Dec 14, 2023 · Past |
| David R. Epstein Other companies: AgomAb Therapeutics NV (Chairman of the Board · Since at least Mar 18, 2026); Tempus AI, Inc. (Director · Since at least Jun 13, 2024); Pfizer, Inc. (Director · Apr 13, 2026 – Nov 5, 2026 · Past); OPY Acquisition I Corp (Director · Oct 26, 2021 – Oct 26, 2021 · Past); Senti Biosciences Holdings, Inc. (Director · May 25, 2021 – Jul 13, 2022 · Past); Axcella Health Inc (Director · May 8, 2019 – May 19, 2022 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Evelo Biosciences, Inc. (Director · May 8, 2018 – Jun 30, 2022 · Past); International Flavors & Fragrances, Inc. (Director · Jan 1, 2016 – Nov 2, 2020 · Past) | CEO, Director · Nov 9, 2022 – Dec 14, 2023 · Past |
| John Orwin Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); CARGO Therapeutics, Inc. (Director · Since at least Nov 9, 2023); AnaptysBio, Inc. (Board Chairman of First Tracks Bio Former CEO of Relypsa · Since at least Sep 15, 2023); Travere Therapeutics, Inc. (Director · Since at least Mar 23, 2017); Atreca Inc (PRESIDENT & CEO, Director · Jun 19, 2019 – Apr 11, 2024 · Past); Relypsa Inc (President & CEO, Director · Nov 14, 2013 – Sep 1, 2016 · Past); Affymax Inc (Director · Apr 12, 2010 – Jun 27, 2013 · Past); NeurogesX Inc (Director · Nov 19, 2009 – Jun 7, 2012 · Past) | Director · Jan 10, 2014 – Dec 14, 2023 · Past |
| Clay Siegall Other companies: Shattuck Labs, Inc. (President, Chairman of the Board of Immunome, Inc. · Since at least Mar 1, 2024); Tourmaline Bio Inc. (Director · Since at least Dec 13, 2023); Immunome, Inc. (President & Chief Executive Officer · Since at least Oct 2, 2023); Nurix Therapeutics, Inc. (Director · May 28, 2021 – May 5, 2022 · Past); Synlogic Inc (Director · Sep 30, 2015 – Jun 29, 2016 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – Oct 22, 2019 · Past); Ultragenyx Pharmaceutical Inc. (Director · Jan 30, 2014 – Aug 7, 2020 · Past) | President & CEO, Director · Jan 31, 2006 – May 12, 2022 · Past |
| John Peter McLaughlin Other companies: LENSAR, Inc. (Director · Sep 17, 2020 – May 25, 2023 · Past); Rockwell Medical, Inc. (Director · Sep 5, 2019 – Jun 17, 2021 · Past); Adverum Biotechnologies Inc (Director · Jul 30, 2014 – Feb 12, 2016 · Past); PDL BioPharma Inc (Director · Oct 8, 2008 – Dec 21, 2020 · Past); Anesiva Inc (Chief Executive Officer, Director · May 10, 2006 – Feb 7, 2008 · Past) | Director · Jun 13, 2007 – May 20, 2016 · Past |
| Nancy Simonian Other companies: Generate Biomedicines, Inc. (Director · Since at least Feb 26, 2026); Evelo Biosciences, Inc. (Director · May 8, 2018 – Jun 17, 2020 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Dec 2, 2024 · Past); Millennium Pharmaceuticals Inc (Chief Medical Officer · May 31, 2007 – May 14, 2008 · Past); ArQule Inc (Director · May 12, 2006 – May 13, 2010 · Past) | Director · Mar 19, 2012 – Dec 14, 2023 · Past |
All 24 people
| Person | Seat |
|---|---|
| Jean Liu Other companies: Connect Biopharma Holdings Limited (Board Director · Since at least Mar 16, 2026); Erasca, Inc. (Board Director · Since at least Apr 25, 2022); Halozyme Therapeutics, Inc. (VP & General Counsel · Dec 8, 2011 – Feb 6, 2014 · Past); Durect Corporation (Chief Legal Officer · Jan 6, 2006 – Jan 28, 2011 · Past) | Chief Legal Officer · Dec 1, 2014 – Dec 14, 2023 · Past |
| Roger Dansey Other companies: Nurix Therapeutics, Inc. (Director · Since at least Nov 6, 2025); Bicycle Therapeutics PLC (Director · Since at least Sep 8, 2025); Kronos Bio Inc (Director · Since at least Apr 20, 2023); Inovio Pharmaceuticals, Inc. (Director · Since at least May 13, 2021) | President, R&D & CMO · May 21, 2018 – Dec 14, 2023 · Past |
| Jonathan G Drachman Other companies: Neurogene Inc. (President and CEO, Director · Aug 8, 2019 – Aug 2, 2022 · Past); Harpoon Therapeutics Inc (Director · Feb 7, 2019 – Mar 8, 2024 · Past); Calithera Biosciences, Inc. (Director · Oct 1, 2014 – Nov 10, 2021 · Past) | CMO & EVP, R & D · Oct 1, 2013 – Mar 20, 2018 · Past |
| Alpna Seth Other companies: Keros Therapeutics, Inc. (Director · Since at least May 1, 2023); Bio-Techne Corp (Director · Since at least Oct 26, 2017) | Director · Mar 15, 2018 – Dec 14, 2023 · Past |
| Thomas C Reynolds Other companies: Lite Strategy, Inc. (Director · Since at least Feb 7, 2013); Trillium Therapeutics Inc (Director · Jan 1, 2021 – Jan 1, 2021 · Past) | Chief Medical Officer · Mar 19, 2007 – Jan 25, 2013 · Past |
| Todd Simpson Other companies: Xencor, Inc. (Director · Since at least Mar 13, 2025); Neurogene Inc. (Director · May 12, 2022 – Jun 8, 2023 · Past) | Chief Financial Officer · Apr 20, 2022 – Dec 14, 2023 · Past |
| Vaughn B Himes Other companies: VBI Vaccines Inc. (Director · Apr 19, 2023 – Jul 27, 2023 · Past); Achieve Life Sciences, Inc. (Director · Mar 14, 2022 – Jan 22, 2024 · Past) | Chief Technical Officer · Apr 1, 2009 – Dec 14, 2023 · Past |
| Charles R. Romp Other companies: Celcuity Inc. (Director · Since at least Feb 11, 2026) | EVP, Commercial U.S. · Apr 15, 2020 – Dec 14, 2023 · Past |
| Daniel Floyd Hoth Jr Other companies: Aduro Biotech Inc (Interim Chief Medical Officer · Nov 29, 2018 – Nov 29, 2018 · Past) | Director · May 15, 2009 – May 21, 2010 · Past |
| Marc E. Lippman Other companies: Ascentage Pharma Group International (Independent non-executive Director · Since at least Mar 18, 2026) | Director · May 20, 2019 – May 14, 2021 · Past |
| Morris Rosenberg Other companies: Immunomedics Inc (Chief Technology Officer · Apr 12, 2018 – Sep 6, 2019 · Past) | EVP, Process Sciences · Mar 13, 2012 – Jun 12, 2012 · Past |
| Sandra M. Swain Other companies: Immunome, Inc. (Director · Since at least Apr 25, 2024) | Director · Nov 9, 2022 – Dec 14, 2023 · Past |
| Pamela A TrailSmith | Chief Scientific Officer · May 17, 2007 – May 17, 2007 · Past |
| Robin G Taylor | Chief Commercial Officer · May 20, 2019 – Dec 19, 2019 · Past |
Log in to ask 6ix AI your own questions about Seagen Inc.